Association between fasting insulin and C-reactive protein among adults without diabetes using a two-part model: NHANES 2005-2010.

Diabetology & Metabolic Syndrome
Amanda L MisselXuefeng Liu

Abstract

Chronic inflammation is associated with the development, progression and long-term complications of type 2 diabetes. Hyperglycemia is associated with chronic low-grade inflammation, and thus has become the focus of many screening and treatment recommendations. We hypothesize that insulin may also be associated with inflammation and may be an additional factor to consider in screening and treatment. This study used National Health and Nutrition Examination Survey data from 2005 to 2010 to analyze the association between fasting insulin and C-reactive protein (CRP). A two-part model was used due to the high number of values reported as 0.1 mg/L. Two models were analyzed, both with and without the addition of waist circumference to other covariates in the model. The final sample included 4527 adults with a mean age of 43.31 years. In the first model, higher fasting insulin was associated with increased odds of CRP > 0.1 mg/L (OR = 1.02, p < .001) and with higher CRP (β = 0.03, p < .001). In the adjusted model, including waist circumference as a covariate, higher fasting insulin was not associated with CRP > 0.1 mg/L (OR = 1.00, p = .307) but the association between higher fasting insulin and higher continuous CRP remained signific...Continue Reading

References

Apr 11, 1996·The New England Journal of Medicine·J P DesprésP J Lupien
Jan 11, 2000·Stroke; a Journal of Cerebral Circulation·B LindahlB Stegmayr
Apr 15, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Aruna D PradhanPaul M Ridker
Jan 15, 2011·Nature Reviews. Immunology·Marc Y Donath, Steven E Shoelson
Mar 18, 2011·Current Opinion in Lipidology·De-xiu BuAndrew H Lichtman
Dec 12, 2012·Cell Metabolism·Arya E MehranJames D Johnson
Nov 5, 2014·Therapeutic Advances in Chronic Disease·Chris R Triggle, Hong Ding
Feb 20, 2015·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Antonio Cabrera de LeónMaría del Cristo Rodríguez Pérez
Jul 3, 2015·Molecular Metabolism·David J PedersenMichael P Czech
Nov 16, 2018·BMJ : British Medical Journal·Cara B EbbelingDavid S Ludwig
Jul 11, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Amar AliUNKNOWN As part of The Improving Diabetes Steering Committee
Sep 19, 2019·Journal of the Endocrine Society·Dylan D ThomasCaroline M Apovian
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association
Feb 6, 2020·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberGuillermo E Umpierrez

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

Stata

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.